Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hypersensitivity D006967 22 associated lipids
Pulmonary Edema D011654 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Fibrosis D005355 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Endotoxemia D019446 27 associated lipids
Glioblastoma D005909 27 associated lipids
Neuralgia D009437 28 associated lipids
Insulinoma D007340 28 associated lipids
Proteinuria D011507 30 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Anaphylaxis D000707 35 associated lipids
Acne Vulgaris D000152 35 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Taha TA et al. Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. 2004 Biochim. Biophys. Acta pmid:15158755
Duong CQ et al. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages. 2004 Biochim. Biophys. Acta pmid:15158762
Zhou H and Murthy KS Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. 2004 Am. J. Physiol., Cell Physiol. pmid:15075212
Hung RJ et al. Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts. 2004 Am. J. Physiol., Cell Physiol. pmid:15075215
Wang W et al. Physiological sphingosine 1-phosphate requirement for optimal activity of mouse CD4+ regulatory T Cells. 2004 FASEB J. pmid:15084513
Dudek SM et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. 2004 J. Biol. Chem. pmid:15056655
Saba JD and Hla T Point-counterpoint of sphingosine 1-phosphate metabolism. 2004 Circ. Res. pmid:15059942
Miura Y et al. Independence of tumor necrosis factor-alpha-induced adhesion molecule expression from sphingosine 1-phosphate signaling in vascular endothelial cells. 2004 J. Thromb. Haemost. pmid:15140149
Garg SK et al. Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo. 2004 J. Infect. Dis. pmid:15143482
Hale JJ et al. Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. 2004 Bioorg. Med. Chem. Lett. pmid:15149705
Oshima Y et al. Intraocular gutless adenoviral-vectored VEGF stimulates anterior segment but not retinal neovascularization. 2004 J. Cell. Physiol. pmid:15095287
Meacci E et al. Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblasts. 2004 Biochem. J. pmid:15109308
Lim HS et al. Syntheses of sphingosine-1-phosphate analogues and their interaction with EDG/S1P receptors. 2004 Bioorg. Med. Chem. Lett. pmid:15109640
Peng X et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. 2004 Am. J. Respir. Crit. Care Med. pmid:15020292
Panetti TS et al. Extracellular matrix molecules regulate endothelial cell migration stimulated by lysophosphatidic acid. 2004 J. Thromb. Haemost. pmid:15333043
Jin ZQ et al. Sphingosine kinase activation mediates ischemic preconditioning in murine heart. 2004 Circulation pmid:15451787
Kang YC et al. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation. 2004 Cell Death Differ. pmid:15297884
Holdsworth G et al. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor. 2004 BMC Biochem. pmid:15298705
Anliker B and Chun J Cell surface receptors in lysophospholipid signaling. 2004 Semin. Cell Dev. Biol. pmid:15271291
Pyne S et al. Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. 2004 Semin. Cell Dev. Biol. pmid:15271294
Galaria II et al. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. 2004 J. Surg. Res. pmid:15555614
Shida D et al. Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells. 2004 FEBS Lett. pmid:15556605
Allende ML et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. 2004 J. Biol. Chem. pmid:15459201
Yamanaka M et al. Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. 2004 J. Biol. Chem. pmid:15485866
Alewijnse AE et al. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. 2004 Br. J. Pharmacol. pmid:15504747
Bhattacharya J Lung injury: sphingosine-1-phosphate to the rescue. 2004 Am. J. Respir. Crit. Care Med. pmid:15504814
Hedemann J et al. Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries. 2004 Auton Autacoid Pharmacol pmid:15541015
Kumar A et al. Sphingosine-1-phosphate plays a role in the suppression of lateral pseudopod formation during Dictyostelium discoideum cell migration and chemotaxis. 2004 Cell Motil. Cytoskeleton pmid:15476260
Sun C and Bittman R An efficient preparation of isosteric phosphonate analogues of sphingolipids by opening of oxirane and cyclic sulfamidate intermediates with alpha-lithiated alkylphosphonic esters. 2004 J. Org. Chem. pmid:15497998
Wang FX et al. mitochondrial ceramidase overexpression up-regulates Bcl-2 protein level in K562 cells, probably through its metabolite sphingosine-1-phosphate. 2004 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15498114
Liu S et al. Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase. 2004 J. Biol. Chem. pmid:15466414
Birukov KG et al. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. 2004 Circ. Res. pmid:15472119
Amano S et al. Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids. 2004 Br. J. Dermatol. pmid:15541073
Xin C et al. Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells. 2004 Br. J. Pharmacol. pmid:15466446
Butler J et al. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells. 2004 Prostaglandins Other Lipid Mediat. pmid:15165029
Chae SS et al. Constitutive expression of the S1P1 receptor in adult tissues. 2004 Prostaglandins Other Lipid Mediat. pmid:15165038
Geoffroy K et al. Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids. 2004 J. Biol. Chem. pmid:15184394
Xin C et al. Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. 2004 J. Biol. Chem. pmid:15192102
Baudhuin LM et al. S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). 2004 FASEB J. pmid:14657000
Otala M et al. Protection from radiation-induced male germ cell loss by sphingosine-1-phosphate. 2004 Biol. Reprod. pmid:14613902
McVerry BJ et al. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. 2004 Am. J. Respir. Crit. Care Med. pmid:15282202
Ogretmen B and Hannun YA Biologically active sphingolipids in cancer pathogenesis and treatment. 2004 Nat. Rev. Cancer pmid:15286740
Sutphen R et al. Lysophospholipids are potential biomarkers of ovarian cancer. 2004 Cancer Epidemiol. Biomarkers Prev. pmid:15247129
Sauer B et al. Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. 2004 J. Biol. Chem. pmid:15247277
Roviezzo F et al. Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15254297
Hla T Physiological and pathological actions of sphingosine 1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271296
Payne SG et al. Modulation of adaptive immune responses by sphingosine-1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271297
Oskouian B and Saba JD Death and taxis: what non-mammalian models tell us about sphingosine-1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271298
Matsushita K et al. Sphingosine 1-phosphate activates Weibel-Palade body exocytosis. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15273282
Augé N et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. 2004 Circulation pmid:15277330